ReduX

ReduX

ICO Ended
927 Views
In recent months, much attention has been placed on the energy crisis and climate change. Most technologies today put huge stress on the environment. Even though the existing technological machinery aims to ease life, the impact of their application has a negative impact on the environment. This is where ReduX – the first environmentally conscious technology, comes into the picture. ReduX can be applied practically to any industry, and the benefits offered by this technology are immense. The innovative solutions offered by ReduX can help fight energy shortages and climate change.
5.1
TOTAL SCORE
4.6
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 01 Dec 2022 - 31 Dec 2022
Token info
Ticker: REDUX
Platform: Binance Chain
Token Type: BEP20
Available for sale: 30,000,000 REDUX (1.5%)
Financial
ICO Price: 0.12 USD
Accepting: BUSD, USDT, USDC
Eduard M. Barcikowski
Founder Chairman Board of Directors
Participates in a number of projects
Peter Mueller
Founder CEO, Board of Directors
Participates in a number of projects
Moritz Zuellig
Founder CFO, Head Advisory Board
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
ReverseDAO
ReverseDAO is a solution to all of the problems above; it is a platform that connects the Metaverse with real-world assets. Fiat and economic units that are bound with world assets can now be represented, stored, and transferred onto the blockchain just as easily as cryptocurrencies.
Pre-Sale
UNIMOON
“You’ve got to start with the customer experience and work backwards to the technology. You can’t start with the technology and try to figure out where can I sell it.” -Steve Jobs UNIMOON is tokenizing on Polygon Matic. We are building a layer 1 solution building on substrate and auction for a Polkadot parachain. We will be the first interoperable decentralized social media network partnering with Storj for our decentralized cloud data storage needs. Enabling users to have full ownership and control of their personal information where it is displayed and how it is displayed utilizing blockchain technology for storage of key information. UNIMOON is bridging the gap between web2.0 to web3.0 solving the greatest issue of adoption for blockchain technology in the simplest way possible starting with the user experience.
Upcoming
Vidy
Vidy is the world's first decentralized ad network, powered by the ethereum blockchain. Vidy's ad platform allows advertisers to embed video ads directly into hyper-relevant website text, improving user experience, ad conversions and publisher payments. With just a hold, users can now reveal tiny hyper-relevant videos embedded in the text of any page on the web, unlocking a whole new dimension of the internet. All ads are placed with an NLP consensus protocol driven by miners. With a team of veteran engineers, industry-leading advisors and world-class brand partners, Vidy is on it's way to reinventing online advertising, e-commerce, and entertainment.
Upcoming
Cure Cosplay
Cure WorldCosplay is the world’s largest Cosplay platform, supporting 12 languages where more than 720,000 members from more than 180 countries post their quality works - 6.5 million images and counting. Our official social media accounts are followed by more than 430,000 people across Facebook, Twitter, and Weibo. We have a strong emphasis on providing community service which is characterized by self-sustainability and development. Cosplayers have various motivations for their activity, some Cosplayer want to become professional, others want more fans, and yet others are looking to share their work with groups. Photographers and Props Makers working closely with Cosplayers also have some influence on the increasing diversity of motivations. COT will be used as a payment currency within the Cure WorldCosplay ecosystem, helping cosplayers without access to other online payment methods to be tipped for their services. Using the Cure Protocol, players will also be able to create and distribute their own personalised coin. This unique feature will bring power back to cosplayers, enabling them to monetize themselves as these coins can be used to tip players as well as purchase merchandise or event tickets. Player Coins will provide an accessible platform for cosplayers to promote their identity to the continuously growing 720,000 member-base of Cure WorldCosplay, as they will be directly attainable by fans. These coins will also allow cosplayers to develop deeper relationships with their communities, as users will be able to explicitly show their support while also gamifying their experience.
Upcoming
Plentix
The advent of cryptocurrencies and the tokenized economy makes it possible to re-imagine the entire value chain of consumer, products, and producers from a referral perspective. We present Plentix, a tokenized platform that enables users to refer other users to a business entity and enables business entities to leverage existing APIs for industry specific referrals and allows for safe, secure, trustless value exchange to take place. Unlike other referral platforms, Plentix unleashes the potential of a new global ecosystem to monetize referrals for every stakeholder, from the producer to the consumer.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.